Replies to post #15184 on Fuse Science Inc (DROP)

[scooter28]

I take their sentence as true, because the way I read it, they are only talking maximum in the area of buccal and oral.

also, IF!!! they have this molecular science which enables them to encapsulate more molecules than anyone else, and IF!!! it is testing out positive for so many possibilities, (anyone worth their salt in due diligence recalls Tuffin's, "It is our firm belief") --- due diligence finishes his quote, then I'm not so sure they would sell to pharma if they were holding all the cards.

don't forget, Durschlag sold all his patent-pending rights to Fuse except one, which he has licensed to Fuse for 30 years. (I wonder what that one is?) Fuse still can manuver with the "rented" license, but Durschlag is making money on that one ever since Fuse bought him out. Mainly, Durschlag is like us, (but with about 6M more shares), as he only makes "real" money when the stock heads north.

[scooter28]

re. your last sentence mdub, I have expressed concerns about Fuse's ability to do this outside of social media. (and even with the power of social media, adding up all the followers of our athletes, how much is all this when measured up against the entire targeted buying public?) I don't see where Fuse's budget gets us any kind of national attention. (hope I am proven wrong!)

[infoseeker11]

The Drops about to launch will be interesting to watch from a Sales perspective. As technology grows everything seems to get "smaller and faster."

Just like your example below. From a 32 oz. Gatorade to a 16oz can of Monster, to an 8oz Can of Red Bull to a 2oz shot of 5 hour energy. The progression and acceptance of smaller equally if not more effective/healthy products have been accepted well in the market.

Now we have a Drop, that will enter the system in less than 90 seconds and provide an equal boost, electrolyte amount and nutrient formula as products that require larger consumption and dosing.

My belief is that it too will be received well.

As for the Pharma side, time will tell where this is going. We will get an update of some kind on the PR from December based on my response from IR.

Fuse Science, Inc. (www.fusescience.com), announced today the formal launch of its Hypoglycemic, Hyperglycemic, and Analgesic project platforms for the advancement of its OTC and pharmaceutical licensing efforts.

"We are extremely passionate about our work in this area," said Ed Maliski, Ph.D. & Lead scientist. "Our work is born out of diabetes sufferers on staff who are committed to advancing these platforms with sense of urgency. We have produced significant results with our OFD work and feel very confident at this stage with our ability to advance these project platforms."

One reason the "patent pending technology" is intriguing to me is that it could be a dosage control mechanism that would allow a sufficient, but precise amount of medication to be delivered, while still allowing for the digestive system to be bypassed (a device that works somewhere between a standard dropper and a teaspoon of liquid ibuprofen).

I believe you are SPOT ON here. Like Scooter said, Durshlag kept 1 patent.... License, the device and ...... well you know results the that would provide.